Transcatheter closure of atrial septal defect and patent foramen ovale with Carag bioresorbable septal occluder: first-in-man experience with 24-month follow-up.
作者信息
Sievert Kolja, Bertog Stefan, Söderberg Björn, Gafoor Sameer, Hofmann Ilona, Grunwald Iris, Schnelle Nalan, Sievert Horst
机构信息
CardioVascular Center Frankfurt CVC, Frankfurt, Germany.
Department of Pediatrics at Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden.
出版信息
EuroIntervention. 2022 Apr 22;17(18):1536-1537. doi: 10.4244/EIJ-D-21-00740.
Abstract
摘要
相似文献
1
Transcatheter closure of atrial septal defect and patent foramen ovale with Carag bioresorbable septal occluder: first-in-man experience with 24-month follow-up.使用卡拉格生物可吸收房间隔封堵器经导管闭合房间隔缺损和卵圆孔未闭：首例人体经验及24个月随访
EuroIntervention. 2022 Apr 22;17(18):1536-1537. doi: 10.4244/EIJ-D-21-00740.
2
Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.使用单个Amplatzer卵圆孔未闭封堵器闭合并存的继发孔型房间隔缺损和卵圆孔未闭。
Cardiovasc Revasc Med. 2010 Jan-Mar;11(1):63-6. doi: 10.1016/j.carrev.2008.09.004.
3
Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.经皮房间隔分流封堵术对偏头痛发作的影响：单术者系列研究及文献综述
Rev Recent Clin Trials. 2017;12(2):129-138. doi: 10.2174/1574887112666170328124939.
4
Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.大型队列中经导管房间隔缺损封堵术：中期随访结果
Congenit Heart Dis. 2013 Sep-Oct;8(5):418-27. doi: 10.1111/chd.12057. Epub 2013 Apr 22.
5
Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.Amplatzer封堵器与CardioSEAL/STARFlex封堵器：卵圆孔未闭和房间隔缺损经导管封堵术疗效与安全性的荟萃分析
Cardiol Young. 2013 Aug;23(4):582-96. doi: 10.1017/S1047951112001424. Epub 2012 Dec 3.
6
Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.使用普通荧光透视法简化经皮闭合卵圆孔未闭和房间隔缺损：110例连续患者的单操作者经验
Indian Heart J. 2018 Jan-Feb;70(1):24-31. doi: 10.1016/j.ihj.2017.07.020. Epub 2017 Aug 8.
7
Safety and efficacy of the Amplatzer™ Trevisio™ intravascular delivery system: Post-approval study results.Amplatzer™ Trevisio™ 血管内输送系统的安全性和有效性：上市后研究结果。
Arch Cardiovasc Dis. 2023 Dec;116(12):580-589. doi: 10.1016/j.acvd.2023.10.006. Epub 2023 Oct 26.
8
Atrial septal defect and patent foramen ovale: early and long-term effects on endothelial function after percutaneous occlusion procedure.房间隔缺损和卵圆孔未闭：经皮封堵术后对内皮功能的早期和长期影响。
Heart Vessels. 2019 Sep;34(9):1499-1508. doi: 10.1007/s00380-019-01385-2. Epub 2019 Mar 20.
9
Transcatheter Closure of Atrial Septal Defect with Carag Bioresorbable Septal Occluder™: First-in-Child Experience with 12-MonthFollow-Up.经导管房间隔缺损封堵术联合 Carag 可吸收房间隔封堵器™：在儿童中应用的初步经验及 12 个月随访结果。
J Interv Cardiol. 2022 Dec 30;2022:3476398. doi: 10.1155/2022/3476398. eCollection 2022.
10
Closure of patent foramen ovale after surgery with atrial septal defect occluder accompanied by Marfan syndrome.使用房间隔缺损封堵器并伴有马凡综合征的手术后卵圆孔未闭的闭合
Eur Heart J. 2023 May 21;44(20):1840. doi: 10.1093/eurheartj/ehad159.
引用本文的文献
1
Interventions for adult congenital heart disease.成人先天性心脏病的干预措施。
Nat Rev Cardiol. 2025 Jan 20. doi: 10.1038/s41569-025-01118-1.
2
Recent Development of Biodegradable Occlusion Devices for Intra-Atrial Shunts.用于心房分流的可生物降解封堵装置的最新进展
Rev Cardiovasc Med. 2024 May 8;25(5):159. doi: 10.31083/j.rcm2505159. eCollection 2024 May.
3
Biodegradable Cardiac Occluder with Surface Modification by Gelatin-Peptide Conjugate to Promote Endogenous Tissue Regeneration.表面修饰的可生物降解心脏封堵器用明胶-肽缀合物促进内源性组织再生。
Adv Sci (Weinh). 2024 Jan;11(2):e2305967. doi: 10.1002/advs.202305967. Epub 2023 Nov 20.
4
Transcatheter Closure of Atrial Septal Defect with Carag Bioresorbable Septal Occluder™: First-in-Child Experience with 12-MonthFollow-Up.经导管房间隔缺损封堵术联合 Carag 可吸收房间隔封堵器™：在儿童中应用的初步经验及 12 个月随访结果。
J Interv Cardiol. 2022 Dec 30;2022:3476398. doi: 10.1155/2022/3476398. eCollection 2022.
5
Atrial Septal Defect Closure With the ReAces Device: Burning No Bridges.使用ReAces装置闭合房间隔缺损：不留后患。
JACC Basic Transl Sci. 2022 Dec 26;7(12):1211-1213. doi: 10.1016/j.jacbts.2022.07.010. eCollection 2022 Dec.
6
Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease.先天性心脏病的经导管器械治疗与先进成像技术的整合
Children (Basel). 2022 Apr 2;9(4):497. doi: 10.3390/children9040497.
本文引用的文献
1
Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study.应用 Amplatzer 房间隔封堵器闭合继发孔型房间隔缺损：前瞻性、多中心、上市后研究。
Circ Cardiovasc Interv. 2017 Aug;10(8):e004212. doi: 10.1161/CIRCINTERVENTIONS.116.004212.
2
Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.经皮卵圆孔未闭封堵三种不同装置随机对照试验的长期结果。
Eur Heart J. 2013 Nov;34(43):3362-9. doi: 10.1093/eurheartj/eht283. Epub 2013 Jul 9.
Zotero 插件